Renaissance Technologies’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $341M | Sell |
|
|||||
2025
Q1 | $474M | Sell |
|
|||||
2024
Q4 | $715M | Buy |
|
|||||
2024
Q3 | $975M | Sell |
|
|||||
2024
Q2 | $1.31B | Sell |
|
|||||
2024
Q1 | $1.38B | Sell |
|
|||||
2023
Q4 | $1.43B | Sell |
|
|||||
2023
Q3 | $1.48B | Sell |
|
|||||
2023
Q2 | $1.52B | Sell |
|
|||||
2023
Q1 | $1.72B | Sell |
|
|||||
2022
Q4 | $1.71B | Sell |
|
|||||
2022
Q3 | $1.53B | Sell |
|
|||||
2022
Q2 | $1.95B | Sell |
|
|||||
2022
Q1 | $2.04B | Sell |
|
|||||
2021
Q4 | $2.14B | Sell |
|
|||||
2021
Q3 | $2.08B | Sell |
|
|||||
2021
Q2 | $2.03B | Sell |
|
|||||
2021
Q1 | $1.68B | Sell |
|
|||||
2020
Q4 | $1.87B | Sell |
|
|||||
2020
Q3 | $1.95B | Sell |
|
|||||
2020
Q2 | $1.88B | Buy |
|
|||||
2020
Q1 | $1.68B | Buy |
|
|||||
2019
Q4 | $1.52B | Buy |
|
|||||
2019
Q3 | $1.28B | Buy |
|
|||||
2019
Q2 | $1.15B | Buy |
|
|||||
2019
Q1 | $1.12B | Buy |
|
|||||
2018
Q4 | $956M | Buy |
|
|||||
2018
Q3 | $927M | Buy |
|
|||||
2018
Q2 | $883M | Buy |
|
|||||
2018
Q1 | $842M | Buy |
|
|||||
2017
Q4 | $844M | Buy |
|
|||||
2017
Q3 | $691M | Buy |
|
|||||
2017
Q2 | $580M | Sell |
|
|||||
2017
Q1 | $563M | Buy |
|
|||||
2016
Q4 | $500M | Sell |
|
|||||
2016
Q3 | $609M | Buy |
|
|||||
2016
Q2 | $696M | Buy |
|
|||||
2016
Q1 | $692M | Sell |
|
|||||
2015
Q4 | $749M | Sell |
|
|||||
2015
Q3 | $714M | Sell |
|
|||||
2015
Q2 | $771M | Sell |
|
|||||
2015
Q1 | $775M | Sell |
|
|||||
2014
Q4 | $661M | Sell |
|
|||||
2014
Q3 | $767M | Sell |
|
|||||
2014
Q2 | $783M | Buy |
|
|||||
2014
Q1 | $734M | Sell |
|
|||||
2013
Q4 | $603M | Buy |
|
|||||
2013
Q3 | $531M | Buy |
|
|||||
2013
Q2 | $433M | Buy |
|